Parent perceptions of emergent blood transfusion in children

Transfusion. 2023 May:63 Suppl 3:S35-S45. doi: 10.1111/trf.17334. Epub 2023 Apr 18.

Abstract

Background: RhD-negative blood products are in chronic short supply leading to renewed interest in utilizing RhD-positive blood products for emergency transfusions. This study assessed parental perceptions of emergency RhD-positive blood use in children.

Methods: A survey of parents/guardians was conducted on their tolerance of transfusing RhD-positive blood to RhD-negative female children ≤17 years old at four level 1 pediatric hospitals.

Results: In total, 621 parents/guardians were approached of whom 378/621 (61%) completed the survey in its entirety and were included in the analysis. Respondents were mostly females [295/378 (78%)], White [242/378 (64%)], had some college education [217/378 (57%)] and less than $60,000 annual income [193/378 (51%)]. Respondents had a total of 547 female children. Most children's ABO [320/547 (59%)] and RhD type [348/547 (64%)] were not known by their parents; of children with known RhD type, 58/186 (31%) were RhD-negative. When the risk of harm to a future fetus was given as 0-6%, more than 80% of respondents indicated that they were likely to accept RhD-positive blood transfusions on behalf of RhD-negative female children in a life-threatening situation. The rate of willingness to accept emergent RhD-incompatible blood transfusions significantly increased as the potential survival benefit of the transfusion increased.

Conclusion: Most parents were willing to accept RhD-positive blood products on behalf of RhD-negative female children in an emergency situation. Further discussions and evidence-based guidelines on transfusing RhD-positive blood products to RhD-unknown females in emergency settings are needed.

Keywords: D-alloimmunization; RhD-positive blood; hemolytic disease of the fetus and newborn; pediatric trauma; whole blood.

MeSH terms

  • Adolescent
  • Blood Group Incompatibility
  • Blood Transfusion
  • Child
  • Female
  • Fetus
  • Humans
  • Male
  • Rh-Hr Blood-Group System*
  • Transfusion Reaction*

Substances

  • Rh-Hr Blood-Group System